Pin Oak Investment Advisors Inc Amgen Inc Transaction History

Pin Oak Investment Advisors Inc

$104 Million
Q1 2024

A detailed history of Pin Oak Investment Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Pin Oak Investment Advisors Inc holds 291 shares of AMGN stock, worth $90,466. This represents 0.08% of its overall portfolio holdings.

Number of Shares

291

Previous 291 -0.0%

Holding current value

$90,466

Previous $84,000 1.19%

% of portfolio

0.08%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $25,570 - $28,845	-100 Reduced 25.58%	291 $84,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $22,579 - $27,520	100 Added 34.36%	391 $95,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $7,382 - $8,215	-32 Reduced 9.91%	291 $71,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $18,862 - $21,981	-85 Reduced 20.83%	323 $80,000
Q4 2020 Feb 19, 2021	SELL	$216.38 - $257.67 $27,047 - $32,208	-125 Reduced 23.45%	408 $94,000

Q1 2020 May 18, 2020	SELL	$182.24 - $241.7 $4,191 - $5,559	-23 Reduced 4.14%	533 $108,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $8,136 - $10,457	-43 Reduced 7.18%	556 $134,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $23,678 - $28,372	-136 Reduced 18.5%	599 $116,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $18,170 - $21,299	109 Added 17.41%	735 $135,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $13,746 - $15,494	76 Added 13.82%	626 $119,000
Q4 2018 Feb 26, 2019	BUY	$178.4 - $208.25 $29,079 - $33,944	163 Added 42.12%	550 $107,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $926 - $1,044	-5 Reduced 1.28%	387 $80,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $847 - $990	-5 Reduced 1.26%	392 $67,000
Q4 2017 Feb 20, 2018	BUY	$168.79 - $188.59 $67,009 - $74,870	397	397 $69,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pin Oak Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pin Oak Investment Advisors Inc with notifications on news.

Account

Pin Oak Investment Advisors Inc Amgen Inc Transaction History